Email This Article
Headlines & Perspectives
Muddled Data Dents Medarex Shares
By
Adam Feuerstein
12/10/07 - 07:15 PM EST
The stock falls after disappointing news on the company's melanoma drug.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.




View Directory